Medical/Pharmaceuticals

TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS

VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the medical potential of the body's ability to self-repair and regenerate, today announced the publication in Frontiers in Phamacology of peer-reviewed research supporting the unique broad spec...

2022-08-31 15:29 1910

NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421

TAIPEI, Aug. 31, 2022 /PRNewswire/ -- United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of NIH. The purpose of this study is to asses...

2022-08-31 12:24 2533

NuraLogix researchers announce AI models that can predict Blood Biomarker Risk

TORONTO, Aug. 31, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of HbA1C levels and Fasting Blood Glucose levels being above a significant clinical threshold for pre-diabetes....

2022-08-31 11:32 2698

Antengene Announces Interim 2022 Financial Results and Provides Corporate Update

- Revenue of RMB 53.96 million mainly driven by the commercial launch of XPOVIO®  (selinexor) in Mainland China onMay 13, 2022 - Adjusted loss reduced to RMB 126 million for the first six months of 2022 fromRMB 210 million in the same period last year - Cash and bank balances of RMB 2.151 billion...

2022-08-31 08:29 3678

Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area

NANNING, China, Aug. 31, 2022 /PRNewswire/ -- Recently, the lung CT image-aided diagnosis software developed by Guangxi Yizhun Intelligent Technology Co., Ltd. ("Yizhun") in National Nanning Economic & Technological Development Area ("Area") has been granted the registration certificate of class ...

2022-08-31 00:32 3113

ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare

The fully connected environment, digital technologies and artificial intelligence tools enable optimization of patient care.  JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ -- ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advanc...

2022-08-30 22:00 3329

LifeTech Scientific Corporation (1302.HK) Announces 2022 Interim Results

* Revenue increased by 20.4%, net profit attributable to owners of the  Company increased by 34.4% after excluding certain non-recurring items SHENZHEN, China, Aug. 30, 2022 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally ...

2022-08-30 21:45 5544

Optina Diagnostics Earns Frost & Sullivan's 2022 North American Technology Innovation Leadership Award for Leveraging Innovative Eye Imagery and Artificial Intelligence for Chronic Diseases Detection including Alzheimer's

Optina Diagnostics' solutions enable specialists and primary care physicians to diagnose chronic diseases including Alzheimer's with reliable and precise retinal scans. SAN ANTONIO, Aug. 30, 2022 /PRNewswire/ -- Based on its recent analysis of the North American Hyperspectral Retinal Imaging Ind...

2022-08-30 20:00 2881

VitalLife Achieves GHA's Certification for Excellence in Medical Travel Patient Experience

PALM BEACH GARDENS, Fla., Aug. 30, 2022 /PRNewswire/ -- VitalLife Scientific Wellness Center in Bangkok, Thailand has achieved Certification for Excellence in Medical Travel Patient Experience byGlobal Healthcare Accreditation (GHA).

2022-08-30 18:00 3516

'Medlab Asia & Asia Health 2022' to Promote Thailand as a Medical Hub of ASEAN by Collaborating with Department of Health Service Support and Medical Industry

BANGKOK, Aug. 30, 2022 /PRNewswire/ -- 'Medlab Asia & Asia Health 2022' is the leading medical event in the ASEAN region which is all set to run in Thailand for the first time, co-hosted by IMPACT Exhibition Management and Informa Markets, and supported by Department of Health Service Support, Mi...

2022-08-30 15:35 3097

Baxter Hosts 2022 Digital Surgery Summit: Reimagining Connected Surgery

 Inspiring surgical innovation for patient care based on connectivity SINGAPORE, Aug. 30, 2022 /PRNewswire/ -- Baxter International Inc.  recently held the 2022 Digital Surgery Summit themed Reimagining Connected Surgery on 9 July inSingapore to accelerate innovation in ...

2022-08-30 10:10 3572

New report highlights the technology key to fighting future pandemics

MELBOURNE, Australia, Aug. 30, 2022 /PRNewswire/ -- CSIRO, Australia's national science agency, has outlined the science and technology that can help improve resilience to future pandemics, reduce their economic impact and protect communities. The Strengthening Australia's Pandemic Preparedness ...

2022-08-30 04:00 4779

Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

Data showed an excellent safety profile with no adverse events among the five subjects treated. Company continues to explore doses in the ongoing Phase II dose escalation study GAITHERSBURG, Md and SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock ...

2022-08-29 15:59 4194

Össur Acquires Naked Prosthetics

HÄMEENLINNA, Finland, Aug. 29, 2022 /PRNewswire/ -- Össur has acquired Naked Prosthetics, a leading provider of durable, custom and functional finger prostheses for finger and partial hand amputees, with effect from26 August 2022 . The mechanical devices are individually designed to mimic the natu...

2022-08-29 15:32 2760

Recbio Announces Interim results for the Fiscal Year 2022 and Company Progress

* The nine-valent HPV vaccine and other blockbuster varieties have been advanced efficiently. * Cash reserve was nearly RMB 1.5 billion, which provided support to sustainable innovation and commercialization. * The novel adjuvants vaccine will create a strong growth engine. TAIZHOU, China, ...

2022-08-29 13:08 5135

Fosun International Listed in Forbes 2022 China ESG 50

HONG KONG, Aug. 29, 2022 /PRNewswire/ -- Forbes China recently released its "2022 China ESG 50" list. Fosun International has been included on the list for its outstanding ESG performance and its active contribution to the fight against the COVID-19 pandemic.Forbes China pointed out that ESG is s...

2022-08-29 12:52 4987

Infinitus co-organizes "Traditional Chinese Medicine Cultural Communication ▪ We are in Action" event

CAE academician Yu Mengsun and Master of traditional Chinese medicine Zhou Daihan visit Infinitus  GUANGZHOU, China, Aug. 27, 2022 /PRNewswire/ -- On August 21, 2022, the Guangdong leg of the "Traditional Chinese Medicine Cultural Communication · We are in Action" event, jointly organized by the...

2022-08-27 09:15 8387

Ocumension Releases its 2022 Interim Report with its core product Youshiying® being approved for marketing, continuously accelerating product commercialization

BEIJING, Aug. 26, 2022 /PRNewswire/ -- On August 26, 2022 (Beijing time), Ocumension Therapeutics (1477.HK) released its 2022 interim report. The Company's overall performance remained remarkable despite the fact that the pandemic caused considerable trouble in commercializing its ophthalmic prod...

2022-08-26 22:09 13141

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

GAITHERSBURG, Md. and SUZHOU, China, Aug. 26, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the advancement of its GalAhead™ RNAi delivery platform f...

2022-08-26 21:54 11230

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference

Oral presentation characterizes promising PK/PD properties of KP104 in relevant animal models and supports its further development as a potent bifunctional complement inhibitor suitable for both intravenous and subcutaneous administration Poster presentations demonstrate synergistic effects of s...

2022-08-26 19:30 3635
1 ... 298299300301302303304 ... 381

Week's Top Stories